Sarepta Therapeutics, Inc.

SRPT Healthcare
$21.55 +$0.02 (0.09%)
Market Cap: $2.26 B
Gurus Holding
5
Popularity Rank
#1938
% of Shares Held
69.98%
Net Activity (Q3 2025)
+$133.32 M

Guru Ownership Over Time

Guru Analysis for Sarepta Therapeutics, Inc. (SRPT)

Sarepta Therapeutics, Inc. (SRPT), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2025, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.58 B.

Top institutional holders include Paul Tudor Jones and Renaissance Technologies.

Institutional sentiment is currently Strongly Bullish. This is evidenced by a $133.32 M net inflow during the quarter.

Recent activity highlights Paul Tudor Jones who dramatically increased their stake.

Portfolio Manager % of portfolio Activity Shares Value Peroid
0.11% Add 135261.8% 68,832,803 $63.35 M Q3 2025
0.07% Add 324.4% 2,650,178 $51.07 M Q3 2025
0.02% Add 1015.8% 1,405,675 $26.4 M Q3 2025
0.03% New Buy 352,275 $6.79 M Q3 2025
0.35% Add 33.3% 84,000 $1.62 M Q3 2025

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown(Q3 2025)

+$133.56 M
Total Buy Value
New Buys: 1
Additions: 4
-$239,024
Total Sell Value
Reductions: 0
Sold Out: 2

Guru Consensus (Q3 2025)

Based on recent guru activity
Net Sellers
2
Net Buyers
5

FAQs for Sarepta Therapeutics, Inc. (SRPT)

Top Guru holders include Paul Tudor Jones ($63.35 M), Renaissance Technologies ($51.07 M), Cliff Asness ($26.4 M). Collectively, tracked Gurus hold 73.32 M shares.

Based on recent 13F filings, the sentiment is **Positive (Net Buy)**. There was a net inflow of $133.32 M, with 5 Gurus buying and 2 Gurus selling.

In the recent quarter, 0 Gurus reduced their positions, and 2 Gurus sold out of SRPT completely. Total sell value was $239,024.

Yes, 1 Gurus opened new positions in SRPT, and 4 added to their existing holdings. Total buy value was $133.56 M.